Glembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?
11:47
Share
2014/9/29
Journal of Clinical Oncology (JCO) Podcast
Request Transcript
Frequently requested episodes will be transcribed first
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.